| Revenue growth | Consolidated Q2 revenue +12% YoY, +5% QoQ; gelatin volumes drove growth. |
|---|---|
| Margins | Habitat 5.88%, up 781bps YoY, 358bps QoQ; API still negative. |
| Demand visibility | US capsule demand absent; gelatin demand firm, several new customers added. |
| Management confidence | Balanced to defensive: admitted HPMC and FY27 API targets missed. |
Growth
Consolidated revenue +12% YoY, +5% QoQ, driven by gelatin conversion of idle HPMC lines, not US demand.
Outlook
FY27 API revenue ₹12-15 Cr (from ₹70-80 Cr); subsidiary cash break-even FY28 at ~₹120 Cr revenue.
Risks
US HPMC demand absent; API cash burn needs fresh equity; FY29 clawback targets extended informally.
Last quarter's promises, checked
Partly delivered
- FY27 total debt ₹100-110 Cr → gross debt ₹115.91 Cr at 30 Sep, above range; repayments ₹10-12 Cr/yr not reported (= PARTIAL)
Missed
- FY27 API revenue ₹70 Cr (domestic) → guidance cut to ₹12-15 Cr (= MISS)
- FY27 HPMC revenue ₹20 Cr; US line 'expected H2 FY27' → US demand absent, HPMC guidance dropped (= MISS)
- WHO GMP certificate Q2 FY27 → audit delayed (= MISS)
Earnings Call Transcript filed with BSE, NSE: NATCAPSUQ. Summary written with AI assistance from the document.
Natural Capsules Ltd: key numbers
- Share price
- ₹126.19
- Market cap
- ₹131.4 Cr
- Revenue (annual)
- ₹187.2 Cr
- Net profit (annual)
- ₹-24.66 Cr
- P/E (TTM)
- -8.3×Sector 49.0×
- Promoter holding
- 50.92%+0.00% QoQ
- FII holding
- 0.08%Current quarter
Reference market data from a third-party provider, updated daily. Not a valuation or a recommendation.
More from Natural Capsules Ltd
All →Natural Capsules Investor Presentation: Key Takeaways
Q2FY27 revenue ₹51.15 Cr (+12% YoY), EBITDA ₹3.01 Cr (5.88% margin), still PAT loss ₹4.22 Cr. Strategy: API scale-up, regulatory filings, CMO expansion.
Natural Capsules Results Update
Natural Capsules issued a press release on its Q2 and H1 FY27 results, citing volume growth and API restructuring. Management expects EBITDA to hold steady.
Natural Capsules Results Correction
Natural Capsules Ltd filed a corrigendum fixing a decimal error in six-month segment revenue (Capsules ₹9,050.16 Lakhs, API ₹936.31 Lakhs, total ₹9,986.47 Lakhs). The correction does not change reported results.
Natural Capsules Preferential Issue
Natural Capsules allotted 1,12,500 equity shares to a single investor at Rs.178 each on a preferential basis. The allotment is worth about Rs.2.00 Crore.
- Value
- ₹2.00 Cr
Natural Capsules Legal & Regulatory
Natural Capsules was fined ₹10,000 each by NSE and BSE for short board-meeting notice. The company has paid the fines and cited a late valuation report.
- Value
- ₹0.00 Cr
Natural Capsules Q2 FY27 Results: Net Loss of ₹4.2 Cr, Loss Narrows
Natural Capsules Ltd reported revenue from operations of ₹51.1 Cr (+11.6% YoY) and a net loss of ₹4.2 Cr for Q2 FY27.
- Key figure
- Net loss ₹4.2 Cr